The team built a diploid yeast strain in which both copies of the SOD1 gene had been deleted, creating a hybrid background containing roughly 50,000 sequence differences between its two parental genomes. This design allowed the researchers to map, with extraordinary resolution, every loss of heterozygosity event that accumulated as cells divided. After subculturing 32 independent isolates for hundreds of generations, whole-genome sequencing revealed a staggering catalogue of damage. Single nucleotide variations accumulated at 13 times the wild-type rate, loss of heterozygosity rose 12-fold, large chromosomal rearrangements increased 4-fold, and aneuploidy—the gain or loss of entire chromosomes—surged an astonishing 48-fold above normal levels.

The scale and diversity of these lesions underscored that Sod1 deficiency does not merely nudge the genome toward instability; it fundamentally rewrites the rules of genome maintenance. The researchers detected 322 interstitial and 134 terminal loss-of-heterozygosity events across their isolates, occurring at rates 15- and 16-fold higher than in wild-type cells, respectively. Gene conversion tracts—the stretches of DNA copied from one homologous chromosome to repair damage on the other—were also markedly longer in the mutant, averaging 10.8 kilobases compared with 5.9 kilobases in healthy cells. Most structural rearrangements were flanked by Ty retrotransposon sequences, pointing to unequal recombination between repetitive elements as a major driver of large-scale chromosome changes.

Perhaps the most striking result came when the researchers repeated the experiment under anaerobic conditions. Deprived of oxygen, the sod1 mutant’s genomic chaos vanished almost entirely: mutation rates fell to wild-type levels and recombination rates dropped dramatically. Supplementing the growth medium with glutathione, a potent cellular antioxidant, similarly cut mutation and recombination frequencies by more than half. Together, these experiments identified reactive oxygen species as the sole executioner behind the genomic storm, confirming that the instability arises from direct chemical attack on DNA rather than from indirect disruption of repair machinery or metabolic collapse.

The mutational fingerprint left by Sod1 loss proved highly distinctive. All six classes of base substitutions increased, but transversions dominated, particularly C:G to A:T changes concentrated within 5′-CCA-3′ sequence motifs. This pattern is the classic signature of 8-oxoguanine, an oxidized form of guanine that mispairs with adenine during replication, producing the characteristic transversion after a second round of DNA copying. The finding directly implicates 8-oxoguanine overproduction as the molecular engine of Sod1-deficient mutagenesis, and it links the enzyme’s antioxidant function to a specific, measurable chemical lesion on DNA.

Dissecting how cells cope with these lesions revealed a sophisticated hierarchy of repair and bypass. The base excision repair glycosylase Ogg1 emerged as the frontline defense: deleting OGG1 alone caused a 19-fold rise in C:G to A:T transversions, and combining OGG1 deletion with SOD1 deletion produced a synergistic 7.5-fold increase over the ogg1 mutant alone. By these calculations, Ogg1-mediated excision corrects roughly 90 percent of the 8-oxoguanine lesions generated in the absence of Sod1. When repair is overwhelmed, translesion synthesis polymerases take over, and here the outcomes diverge sharply. DNA polymerase eta, encoded by RAD30, performs relatively accurate bypass by inserting cytosine opposite the oxidized base, preventing about a third of the characteristic transversions. In contrast, the error-prone polymerase zeta and its partner Rev1 account for approximately two-thirds of all Sod1-induced point mutations, illustrating the costly trade-off between completing replication and preserving sequence fidelity.

Timing analysis of recombination events added another layer of mechanistic insight. Using a colony-sectoring assay on chromosome IV, the team showed that about 65 percent of mitotic crossovers in sod1 mutants were initiated by double-strand breaks arising during the G1 phase of the cell cycle, closely mirroring the pattern in wild-type cells. Fluorescence microscopy of Rad52 repair foci confirmed a four-fold increase in spontaneous DNA breaks. Intriguingly, the distribution of crossover breakpoints was not random: 33 of 35 events on chromosome IV clustered distal to the SSD1 locus, a bias the researchers traced to post-mutational selection rather than intrinsic recombination hotspots. Restoring a functional SSD1 allele, which improved fitness in the sod1 background, redistributed breakpoints uniformly, demonstrating that observed genomic landscapes reflect both where damage occurs and which recombinant cells survive to form colonies.

The study then turned to human disease, testing eight ALS-associated SOD1 variants in the yeast system. Wild-type human SOD1 fully rescued the growth defects and genomic instability of yeast lacking endogenous Sod1, confirming deep functional conservation. But the clinical variants were not created equal. The H48Q mutation, which disrupts a copper-binding residue essential for catalytic activity, shattered genome stability, producing 8- and 10-fold increases in mutation and recombination rates alongside severe growth impairment. The G85R and S133N variants showed moderate effects, while the well-known A4V, G36R, D90A, and G93A variants remained essentially benign in this context. These results suggest that for a subset of ALS patients, loss of genomic protection—driven by failure to quench nuclear reactive oxygen species—may constitute an additional, mutation-specific pathogenic mechanism beyond the prevailing toxic gain-of-function model of protein aggregation.

Notably, the researchers found that human Sod1 is far more tolerant of amino acid substitutions than its yeast counterpart, a difference they attribute to the extraordinary structural robustness of the human enzyme, which remains stable even in metal-deficient states. This resilience likely reflects evolutionary pressure in long-lived organisms to protect the proteome against decades of somatic mutation. The work also carries a cautionary message for cancer therapy: because tumor cells often depend on elevated Sod1 to manage their oxidative burden, pharmacological inhibition of the enzyme, while potentially cytotoxic, risks triggering a mutational burst that could accelerate the emergence of drug-resistant clones. By mapping the full genomic consequences of antioxidant failure—from single nucleotides to whole chromosomes—this study establishes a mechanistic framework for understanding how metabolic defense and genome integrity are inseparably coupled in eukaryotic life.

Subject of Research: The role of superoxide dismutase 1 in protecting eukaryotic genome stability against oxidative DNA damage

Article Title: Decoupling metabolic defense: Mutational and recombinational chaos in Sod1-deficient cells

Article References: Sui, Y., Zheng, D.-Q., Wang, Y., Zhao, S.-S., Li, K.-J., Ye, C., & Zhang, K. (2026). Decoupling metabolic defense: Mutational and recombinational chaos in Sod1-deficient cells. PLOS Genetics, 22(10), e1012326. https://doi.org/10.1371/journal.pgen.1012326

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012326

Keywords: Sod1, genome instability, reactive oxygen species, 8-oxoguanine, yeast, loss of heterozygosity, aneuploidy, base excision repair, translesion synthesis, ALS, SOD1 mutations, oxidative stress

Jacob Corn, a distinguished Professor of Genome Biology at ETH Zurich, emphasizes a common misunderstanding regarding DNA repair mechanisms. People often associate these repair systems exclusively with defending the genome against external threats such as toxins or radiation exposure. However, the reality is much more complex. Protecting the genome is not merely a reactive response; it is also an essential function that supports cellular stability and survival through the quotidian stresses of cellular life. Repairs occur continuously and preemptively, underscoring the proactive nature of these cellular systems.

Scientists have accumulated substantial knowledge about the repertoire of genes necessary for DNA repair, with over 500 of the estimated 20,000 human protein-coding genes identified as crucial players in this process. Recently, a research team led by Corn embarked on an ambitious project to analyze the intricate interactions of these vital genes. Their findings, published in the esteemed journal Nature, reveal a comprehensive understanding of how cells work to maintain genome integrity. By constructing a detailed map of gene relationships, the researchers have unveiled novel interactions and potential new targets for cancer therapies.

To achieve their ambitious goal, the researchers employed an innovative strategy that involved systematically inactivating pairs of DNA repair genes in cultured human cells. This approach was not without its challenges, as the team sought to analyze nearly 150,000 different gene inactivation combinations. The rigorous nature of this investigation called for a high level of organization and meticulous planning. Lead authors John Fielden and Sebastian Siegner recount the enormous complexity of their study, emphasizing that navigating such a vast landscape of genetic interactions required unprecedented dedication and scholarly rigor.

One of the striking findings from Corn and his team’s work is the concept of redundancy within human cells. When a single repair gene is inactivated, it is often the case that another gene can compensate for the loss, thereby preventing any noticeable effects on cellular function. This redundancy is a hallmark of cellular resilience, allowing cells to withstand minor perturbations in their environment. However, the real risk emerges when both the primary and backup repair genes are disabled. In such scenarios, cellular damage accumulates, eventually reaching lethal levels that compromise cell viability.

The study yielded critical insights into the interplay of molecular interactions that underpin cellular survival in the face of DNA damage. The researchers provided detailed analyses of the specific interactions lost when two particular gene pairs were inactivated, shedding light on previously unrecognized pathways that are essential for cell function. This newfound understanding could usher in a new era of targeted cancer therapies, especially considering that cancer cells often exhibit a higher mutation rate and, consequently, a more significant reliance on specific DNA repair mechanisms.

As cancer cells frequently exhibit a disruption in the activity of many of the 500+ DNA repair genes, the implications of these discoveries are profound. Some of the genes that can be potential therapeutic targets may be shut off in these aberrant cells. By identifying additional genetic vulnerabilities through their research, Corn and his team have paved the way for developing therapeutics that target specific weaknesses within cancer cells.

The researchers’ findings also highlight a critical relationship between common cancer mutations and previously unknown molecular targets. This connection opens up promising avenues for pharmaceutical interventions. By targeting these newly discovered vulnerabilities, researchers could develop drugs that effectively limit the proliferation of cancer cells while sparing normal cells, a dream of oncological research.

To further facilitate collaboration and engagement within the scientific community, Corn and his team have created a user-friendly web platform that hosts their research findings and data. This platform aims to make their results publicly accessible, encouraging other researchers to leverage this knowledge when developing novel cancer microtreatments. By sparking dialogue over shared knowledge and resources, the team hopes to accelerate the translation of these research findings into clinical applications, ultimately leading to more effective cancer therapies.

In summary, the recent study led by Professor Jacob Corn and his team at ETH Zurich represents a significant advance in our understanding of DNA repair mechanisms within human cells. With their groundbreaking analysis and detailed mapping of gene interactions, they have opened a new chapter in genetic research that has the potential to transform cancer treatment strategies. As researchers continue to explore these newly identified pathways, the future of personalized cancer therapy may become increasingly bright, offering hope to countless patients facing this formidable disease.

The insights gained from this remarkable research not only enhance scientific understanding but also reinforce the idea that the fight against cancer is a dynamic and evolving battle. By elucidating the intricacies of DNA repair and mapping the genetic architecture involved, Corn’s team is helping to light the way through what has until now felt like a dark forest.

In this complex terrain of cellular interactions, each discovery brings us one step closer to unlocking the secrets of effective cancer treatment. We are reminded of the power of collaborative research in addressing some of humanity’s most pressing health challenges, transcending barriers and bringing diverse minds together to shine a light on the mysteries of life itself.

As science continues to unravel the complexities of genetics and cellular repair mechanisms, the potential to develop innovative therapies grows exponentially. For researchers around the globe, Corn and his team’s work serves as both an important resource and inspiration, igniting the flames of curiosity and ambition in the ongoing quest to understand human health at the molecular level.

Ultimately, as we venture deeper into the landscape of cancer research, the hope is that each new piece of knowledge can guide us toward more effective prevention measures, treatments, and maybe even cures that harness the complex beauty of our own biology.

Subject of Research: DNA Repair Mechanisms in Human Cells
Article Title: Comprehensive Interrogation of Synthetic Lethality in the DNA Damage Response
News Publication Date: 9-Apr-2025
Web References: https://spidrweb.org/
References: 10.1038/s41586-025-08815-4
Image Credits: ETH Zurich

Keywords: Genome Biology, DNA Repair, Cancer Therapy, Genetic Interactions, Cellular Mechanisms, Synthetic Lethality, Molecular Targets, Cancer Research.